| CAS NO: | 1276528-62-1 |
| 包装: | 250 μg |
| 市场价: | 5292元 |
| Cas No. | 1276528-62-1 |
| 别名 | 扎那米韦-13C,15N2 |
| Canonical SMILES | OC(C1=C[C@H](N[13C]([15NH2])=[15NH])[C@@H](NC(C)=O)[C@@]([C@H](O)[C@H](O)CO)([H])O1)=O |
| 分子式 | C11[13C]H20N2[15N]2O7 |
| 分子量 | 335.3 |
| 溶解度 | Water: slightly soluble |
| 储存条件 | Store at -20°C |
| General tips | For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while. |
| Shipping Condition | Evaluation sample solution : ship with blue ice All other available size: ship with RT , or blue ice upon request |
| 产品描述 | Zanamivir-13C,15N2is intended for use as an internal standard for the quantification of zanamivir by GC- or LC-MS. Zanamivir is a sialic acid analog that inhibits neuraminidase release of newly replicated influenza virus particles.1It has been shown to selectively inhibit the growth of influenza A and B viruses in plaque reduction assays with IC50values ranging from 5 to 14 nM and to directly inhibit influenza A and B virus neuraminidases with IC50values ranging from 0.6 to 7.9 nMin vitro. Intranasal zanamivir administration at 0.4 mg/kg twice daily reduces mortality and viral titers in lung homogenates of mice infected with influenza. 1.Elliott, M.Zanamivir: From drug design to the clinicPhilos. Trans. R. Soc. Lond. B Biol Sci.356(1416)1885-1893(2001) |
m.cnreagent.com